Showing results (61-70 of 171) with videos related to
Sort By:
Pageof 18
Clinical Trials (London, England)|October 1, 2020
Adverse event load, onset, and maximum grade: A novel method of reporting adverse events in cancer clinical trialsGuilherme S Lopes, Christophe Tournigand, Curtis L Olswold, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 14, 2014
False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancerAnya Litvak, Andrea Cercek, Neil Segal, et al.Epigenetics|May 8, 2024
Evaluating the utility of ZNF331 promoter methylation as a prognostic and predictive marker in stage III colon cancer: results from CALGB 89803 (Alliance)Elizabeth S Nakasone, Tyler J Zemla, Ming Yu, et al.Cancer|November 23, 2016
Clinical and genetic determinants of ovarian metastases from colorectal cancerKaruna Ganesh, Ronak H Shah, Efsevia Vakiani, et al.JCO Oncology Practice|June 20, 2022
A Randomized Trial Evaluating Patient Experience and Preference Between Octreotide Long-Acting Release and Lanreotide for Treatment of Well-Differentiated Neuroendocrine TumorsNitya Raj, Elizabeth Cruz, Sarah O'Shaughnessy, et al.Mycorrhiza|August 24, 2016
Monitoring CO2 emissions to gain a dynamic view of carbon allocation to arbuscular mycorrhizal fungiRenata Slavíková, David Püschel, Martina Janoušková, et al.The Oncologist|April 27, 2005
HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forumRomán Pérez-Soler, Jean Pierre Delord, Allan Halpern, et al.Surgery|June 24, 2014
A comparison of colorectal cancer in Nigerian and North American patients: is the cancer biology different?Saurabh Saluja, Olusegun I Alatise, Adisa Adewale, et al.International Journal of Radiation Oncology, Biology, Physics|April 1, 2008
ACR Appropriateness Criteria on resectable rectal cancer: expert panel on radiation oncology--rectal/anal cancerW Warren Suh, A William Blackstock, Joseph Herman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancerJim Cassidy, Stephen Clarke, Eduardo Díaz-Rubio, et al.Pageof 18